RAGE (receptor for advanced glycation end products): a central player in the inflammatory response

Area of Science:

• Immunology
• Cell Biology
• Molecular Medicine

Background:

• The receptor for advanced glycation end products (RAGE) is a key mediator in inflammatory processes.
• RAGE is implicated in cellular dysfunction across various conditions, including inflammatory disorders, tumors, and diabetes.
• RAGE expression is typically low in healthy tissues but significantly increases at sites of ligand accumulation.

Purpose of the Study:

• To review the multifaceted role of RAGE in the inflammatory response.
• To elucidate the mechanisms by which RAGE influences cellular activation and recruitment during inflammation.
• To discuss the dual functions of RAGE as both a signaling receptor and an adhesion molecule.

Main Methods:

• Literature review of studies investigating RAGE function in inflammatory contexts.
• Analysis of RAGE's interaction with its ligands and downstream signaling pathways, such as NF-kappaB.
• Examination of RAGE's role in leukocyte-endothelial cell interactions and inflammatory cell recruitment.

Main Results:

• RAGE activation by its ligands triggers cellular responses, notably involving the transcription factor NF-kappaB.
• RAGE expressed on endothelial cells can act as an adhesive receptor, directly binding to leukocyte ss2-integrins.
• These interactions facilitate inflammatory cell recruitment to sites of inflammation.

Conclusions:

• RAGE plays a critical and complex role in orchestrating inflammatory responses.
• Its dual function in signal transduction and cell adhesion highlights its significance in disease pathogenesis.
• Understanding RAGE's mechanisms is crucial for developing therapeutic strategies against inflammatory diseases, cancer, and diabetes.